本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Repro Med Systems, Inc.

2.47
-0.0200-0.80%
盘后2.470.00000.00%16:05 EDT
成交量:13.37万
成交额:32.80万
市值:1.14亿
市盈率:-18.65
高:2.51
开:2.47
低:2.36
收:2.49
数据加载中...
2025/04/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/07

重要事件披露

Form 8-K - Current report
2025/04/04

重要事件披露

Form 8-K - Current report
2025/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/12

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/12

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/12

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/21

重要事件披露

Form 8-K - Current report
2024/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

重要事件披露

Form 8-K - Current report
2024/07/24

重要事件披露

Form 8-K - Current report
2024/07/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments